Intravenous dopamine in the treatment of myocardial dysfunction after open-heart surgery.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D005934:Glucagon / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006351:Heart Valves / Q000601:surgery; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000209:etiology; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use; D012501:Saphenous Vein / Q000637:transplantation; D014182:Transplantation, Autologous; D014556:Urine / Q000032:analysis; D014655:Vascular Resistance / Q000187:drug effects
D008680:Metaraminol; D005934:Glucagon; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine